Use of CD200 blockade inhibitor to enhance glioma immunotherapy

por Mesias, Elisabet, Xiong, Zhengming, Pluhar, Elizabeth, Olin, Michael
Publicado 2015

SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma

por Ampudia-Mesias, Elisabet, El-Hadad, Samia, Cameron, Charles Scott, Wöhrer, Adelheid, Ströbel, Thomas, Saydam, Nurten, Saydam, Okay
Publicado 2022

Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma

por Olin, Michael R., Ampudia-Mesias, Elisabet, Pennell, Christopher A., Sarver, Aaron, Chen, Clark C., Moertel, Christopher L., Hunt, Matthew A., Pluhar, G. Elizabeth
Publicado 2019

Extracellular-Vesicle-Based Cancer Panels Diagnose Glioblastomas with High Sensitivity and Specificity

por Mut, Melike, Adiguzel, Zelal, Cakir-Aktas, Canan, Hanalioğlu, Şahin, Gungor-Topcu, Gamze, Kiyga, Ezgi, Isikay, Ilkay, Sarac, Aydan, Soylemezoglu, Figen, Strobel, Thomas, Ampudia-Mesias, Elisabet, Cameron, Charles, Aslan, Tulay, Tekirdas, Eray, Hayran, Mutlu, Oguz, Kader Karli, Henzler, Christine, Saydam, Nurten, Saydam, Okay
Publicado 2023